SAC Capital Advisors’s VivoSim Labs VIVS Stock Holding History

SAC Capital Advisors’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-53	Closed	-$139K	–	2007
2013 Q4	$139K	Buy	+53	New	+$104K	﹤0.01%	1688

Other funds holding VIVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAC Capital Advisors's VIVS Position: Q1 2014 in Review

SAC Capital Advisors sold out of VivoSim Labs (VIVS) in Q1 2014, closing a stake of 53 shares — an estimated $139K sold.

SAC Capital Advisors first reported a position in VIVS in Q4 2013 and held it in 1 quarter. The position peaked at $139K in Q4 2013. 94 funds tracked by Wall St. Rank hold VIVS as of Q1 2014.

SAC Capital Advisors reported no remaining VivoSim Labs position as of Q1 2014 after selling out during the quarter.
SAC Capital Advisors sold 53 VivoSim Labs shares in Q1 2014, an estimated $139K.
SAC Capital Advisors first reported a position in VivoSim Labs in Q4 2013 and held it in 1 quarter.
SAC Capital Advisors's VivoSim Labs position peaked at $139K in Q4 2013.
94 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2014.

Based on SAC Capital Advisors's 13F filing for Q1 2014, filed 15 May 2014.